TABLE 2.
Common symptoms | Non-treated group (n = 50) |
MHT group (n = 50) |
P-values | ||||||||||
Asymptomatic | Mild | Moderate | Severe | Extremely severe | Mean ± SD (Mean) | Asymptomatic | Mild | Moderate | Severe | Extremely severe | Mean ± SD (Mean) | ||
Vulvovaginal symptom | 2.32 ± 0.36 (2) | 1.06 ± 0.18 (1) | < 0.01 | ||||||||||
Dryness | 30.00% | 36.00% | 20.00% | 10.00% | 4.00% | 1.22 ± 0.16 (1) | 58.00% | 26.00% | 16.00% | 0.00% | 0.00% | 0.58 ± 0.11 (0) | <0.005 |
Itching | 62.00% | 20.00% | 6.00% | 12.00% | 0.00% | 0.68 ± 0.15 (0) | 68.00% | 22.00% | 10.00% | 0.00% | 0.00% | 0.42 ± 0.10 (0) | 0.366 |
Burning | 78.00% | 10.00% | 4.00% | 8.00% | 0.00% | 0.42 ± 0.13 (0) | 96.00% | 2.00% | 2.00% | 0.00% | 0.00% | 0.06 ± 0.04 (0) | < 0.01 |
Urological symptom | 0.94 ± 0.19 (0) | 0.52 ± 0.16 (0) | 0.051 | ||||||||||
Frequent, urgent, and painful urination | 70.00% | 18.00% | 10.00% | 2.00% | 0.00% | 0.44 ± 0.11 (0) | 84.00% | 14.00% | 2.00% | 0.00% | 0.00% | 0.18 ± 0.06 (0) | 0.072 |
Recurrent urinary tract infection | 90.00% | 2.00% | 8.00% | 0.00% | 0.00% | 0.18 ± 0.08 (0) | 96.00% | 0.00% | 4.00% | 0.00% | 0.00% | 0.08 ± 0.06 (0) | 0.436 |
Incontinence | 74.00% | 20.00% | 6.00% | 0.00% | 0.00% | 0.32 ± 0.08 (0) | 84.00% | 10.00% | 2.00% | 4.00% | 0.00% | 0.26 ± 0.10 (0) | 0.305 |
Sexual symptom | 2.58 ± 0.17 (3) | 1.62 ± 0.20 (1) | < 0.005 | ||||||||||
Decreased libido | 8.00% | 8.00% | 32.00% | 22.00% | 30.00% | 2.58 ± 0.17 (3) | 77.80% | 24.00% | 20.00% | 14.00% | 14.00% | 1.62 ± 0.20 (1) | <0.005 |
GSM | 5.84 ± 0.49 (5) | 3.20 ± 0.41 (2.5) | < 0.005 |
P-value in bold indicates statistical difference is significant.